Un-creative thinking is learned. The question is, can we unlearn it? In this interactive, marketing-focused workshop, Creativity Director Chloe Ambrose will explore why we need to invest in creative thinking and where we can get started.
Cambridge, UK, is renowned for its unique business environment that attracts and supports companies in various sectors. Navigating Labour's potential new policies and impacts on the labour market, and therefore the business landscape, will impact (positively and potentially negatively) the companies in Cambridge. This event has been postponed from September 2024.
If you work in HR or recruitment, are you prepared for the shifts in the labour market and immigration policies under Labour’s new administration? Join Davidson Morris for an insightful session where we’ll explore:
Employee sickness absence and presenteeism can be detrimental to a business. Discover what value the Management Referral can add to your workplace.
A report by the Institute for Public Policy Research (IPPR) has found that the cost of employee sickness to UK businesses reached £103bn in 2023. In addition, employees lose the equivalent of 44 days of productivity through presenteeism as a result of an illness, injury, or specific health conditions.
Join some of the Cambridge Network team and fellow members for an afternoon of networking over tea, cakes and fruit at Cambridge Network Connect (previously known as Making the Most of Membership). If you want to meet like-minded companies and some new people, come and join us for a couple of hours. We’d love to meet you too. No presentations this time (ok, just a short welcome and introduction from our CEO)!
Event timings are:
Guest blog by RSM.
As life sciences businesses grow and evolve, so too does the complexity of their data and third-party access landscape. From startups to mid-sized enterprises, strong cyber security fundamentals are essential to protecting research and intellectual property, safeguarding investor funds and confidence, and ensuring long-term success.
Inaphaea BioLabs, the translational contract research organisation based at MediCity Nottingham, has announced the promotion of Melissa Barr to Head of Scientific Operations.
Melissa joined Inaphaea in 2023 as Lead Scientist. Since then, she has played an instrumental role in delivering preclinical drug discovery projects across oncology and women’s health, as well as leading a team of scientists on-site.
by Alicia Gailliez, Business Development Manager, One Nucleus
Over the past 12 months, One Nucleus has organised 41 events in partnership with 48 sponsors and supporters. These regular sessions were complemented by our flagship events, Genesis, ON Helix and the One Nucleus Annual Awards Dinner.
Looking ahead to 2025
A lack of access to capital, particularly proof-of-concept funding, is stifling growth in the UK’s university spinout sector, according to a recent survey conducted by Symbiosis IP, a part of professional services group Gateley.
Described by one respondent as a “broken funding model”, the sector’s lack of funding and difficulty securing much-needed investment capital, particularly outside of the South East, are two of the most urgent issues facing the university spinout sector.
At CHARM Therapeutics, we are pioneering the future of medicine design through the use of our protein-ligand intelligence platform to deliver next generation small molecule therapeutics.
At CHARM Therapeutics, we are pioneering the future of medicine design through the use of our protein-ligand intelligence platform to deliver next generation small molecule therapeutics.